GeneFerm Biotechnology Co

GeneFerm Biotechnology Co Current Assets

The Current Assets of GeneFerm Biotechnology Co (1796.TWO) as of Oct 19, 2026 is 190.23 M TWD. In the previous year, Current Assets was 282.65 M TWD — a change of -32.70% (lower).

Current Assets

190.23 MTWD

YoY

-32.70%

Last updated:

Current Assets of GeneFerm Biotechnology Co is 2025 190.23 M TWD. Current Assets of GeneFerm Biotechnology Co was 2024 282.65 M TWD. It decreases by -32.70% lower compared to the previous year.

The GeneFerm Biotechnology Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
168.69 M TWD
Jan 1, 2019
190.44 M TWD
Jan 1, 2020
535.58 M TWD
Jan 1, 2021
765.18 M TWD
Jan 1, 2022
373.54 M TWD
Jan 1, 2023
397.13 M TWD
Jan 1, 2024
282.65 M TWD
Jan 1, 2025
190.23 M TWD
The GeneFerm Biotechnology Co Current Assets history
YEARCurrent AssetsYoY
190.23 MTWD-32.70%
282.65 MTWD-28.83%
397.13 MTWD+6.32%
373.54 MTWD-51.18%
765.18 MTWD+42.87%
535.58 MTWD+181.23%
190.44 MTWD+12.89%
168.69 MTWD+2.70%
164.26 MTWD-31.85%
241.04 MTWD+29.61%
185.96 MTWD+16.55%
159.55 MTWD+0.28%
159.11 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneFerm Biotechnology Co Stock analysis

What does GeneFerm Biotechnology Co do? GeneFerm Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Consumer Staples sector and the Consumer products industry. It went public on July 26, 2016, with the ticker symbol 1796.TWO and ISIN TW0001796001. The company focuses on the manufacture and sale of health food and dietary supplements. Its product portfolio includes fermented products, medicinal mushrooms, lactic acid bacteria products, and fruit and vegetable fermented concentrates. GeneFerm also offers related manufacturing services, as well as health food design, research, and development services. The company's headquarters are located in Tainan, Taiwan, and it maintains a website at https://www.geneferm.com/. As a publicly traded entity, GeneFerm Biotechnology Co Ltd is listed on the Taiwan Stock Exchange, providing investors with access to its financial performance and corporate activities. The company's operations are centered around the development and production of health-focused food and supplement products, emphasizing natural and fermented ingredients. Its services extend beyond product manufacturing to include design, R&D, and manufacturing support for health food solutions. The firm has been active in the market since its IPO in 2016, contributing to the consumer staples sector with its specialized health food offerings. GeneFerm Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneFerm Biotechnology Co stock

Current Assets of GeneFerm Biotechnology Co is 190.23 M TWD in 2025.

Current Assets of GeneFerm Biotechnology Co changed from 282.65 M TWD to 190.23 M TWD, representing a -32.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets GeneFerm Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's GeneFerm Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — GeneFerm Biotechnology Co

All Key Metrics — GeneFerm Biotechnology Co